ascophyllum nodosium extract
Description
Skin Brightening, Tyrosinase Inhibitor, Anti-melanogenesis, Anti-aging, Antioxidant, Skin Conditioning
Function
Properties
Regulatory Status
Clinically outstanding for skin brightening: combined with Crithmum maritimum, shown comparable efficacy to 4% hydroquinone + 0.05% tretinoin over 18 weeks in 56 women, inhibiting 13 of 14 melanin synthesis steps. This is a remarkable clinical benchmark for a natural ingredient. Pure skin brightening positioning backed by multi-step melanogenesis inhibition. Heavy metal COA required. Specify fucoidan/phlorotannin content in supplier specification for standardized brightening efficacy.
Permitted in cosmetics; no specific FDA restriction; brightening claims supported by clinical evidence; MoCRA 2026 compliance required
Ratings
Identifiers
No registry identifiers available for this ingredient.